Back to search
FDAFDA · Food and drugs·Recall number D-0127-2024

Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30

Published December 6, 2023 · Recall initiated: November 10, 2023

Summary

FDA records drug Class III recall D-0127-2024, published December 6, 2023 and initiated November 10, 2023. Recalling firm: Teva Pharmaceuticals USA, Inc; Status: Terminated; Lot: Lot #: 100029472, Exp. 2/29/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

OOS for viscosity

What to do

Voluntary: Firm initiated

Get an email if TESTOSTERONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TESTOSTERONE
Manufacturer
Teva Pharmaceuticals USA, Inc
Distributor
USA nationwide
Lot
Lot #: 100029472, Exp. 2/29/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30 recalled?

Yes. FDA published recall D-0127-2024 on December 6, 2023. Reported hazard: OOS for viscosity

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TESTOSTERONE.